VXRT Projected Dividend Yield
Vaxart Inc ( NASDAQ : VXRT )Vaxart is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform. Co.'s oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Co.'s investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. In addition, Co. is in early development of its first therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus. 20 YEAR PERFORMANCE RESULTS |
VXRT Dividend History Detail VXRT Dividend News VXRT Competitors News |
Year | Declaration Date | Ex-Dividend Date | Record Date | Payable Date | Dividend $ Amount |
Total: | 0.0000 |